Carroll Financial Associates’s Amedisys AMED Stock Holding History

Carroll Financial Associates’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$26K	Buy	161 +62	+63%	+$9.96K	﹤0.01%	895
2021 Q3	$14K	Buy	99 +6	+6%	+$1.25K	﹤0.01%	1088
2021 Q2	$22K	Hold	93	–	–	﹤0.01%	1050
2021 Q1	$24K	Buy	93 +15	+19%	+$4.23K	﹤0.01%	962
2020 Q4	$22K	Sell	78 -2	-3%	-$513	﹤0.01%	888
2020 Q3	$18K	Hold	80	–	–	﹤0.01%	886
2020 Q2	$15K	Hold	80	–	–	﹤0.01%	920
2020 Q1	$14K	Hold	80	–	–	﹤0.01%	852
2019 Q4	$13K	Hold	80	–	–	﹤0.01%	975
2019 Q3	$10K	Hold	80	–	–	﹤0.01%	993
2019 Q2	$9K	Buy	+80	New	+$9.49K	﹤0.01%	1034

Other funds holding AMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Carroll Financial Associates's AMED Position: Q4 2021 in Review

Carroll Financial Associates increased its Amedisys (AMED) stake by 63% in Q4 2021, buying an estimated $9.96K and bringing the position to 161 shares worth $26K. The position accounts for ﹤0.01% of the portfolio, ranked #895.

Carroll Financial Associates first reported a position in AMED in Q2 2019 and has held it in 11 quarters since. 325 funds tracked by Wall St. Rank hold AMED as of Q4 2021.

Carroll Financial Associates held 161 shares of Amedisys worth $26K as of Q4 2021.
Carroll Financial Associates bought 62 Amedisys shares in Q4 2021, an estimated $9.96K.
Amedisys made up ﹤0.01% of Carroll Financial Associates's portfolio in Q4 2021, its #895 holding.
Carroll Financial Associates first reported a position in Amedisys in Q2 2019 and has held it in 11 quarters since.
325 funds tracked by Wall St. Rank held Amedisys as of Q4 2021.

Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.